n-glycylalanine has been researched along with EBV Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kenney, SC; Sun, X | 1 |
| Coppotelli, G; Masucci, MG; Mughal, N | 1 |
2 other study(ies) available for n-glycylalanine and EBV Infections
| Article | Year |
|---|---|
Hsp90 inhibitors: a potential treatment for latent EBV infection?
Topics: Antiviral Agents; Benzoquinones; Dipeptides; Epstein-Barr Virus Infections; Herpesvirus 4, Human; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Viral Proteins | 2010 |
The Gly-Ala repeat modulates the interaction of Epstein-Barr virus nuclear antigen-1 with cellular chromatin.
Topics: Cell Line, Tumor; Chromatin; Dipeptides; Epstein-Barr Virus Infections; Epstein-Barr Virus Nuclear Antigens; Fluorescence Recovery After Photobleaching; Herpesvirus 4, Human; Humans; Interphase; Mitosis; Protein Structure, Tertiary; Repetitive Sequences, Amino Acid; Sequence Deletion; Virus Latency | 2013 |